Mr Nick Stephens Appointed Chairman of the Board

Mr Nick Stephens Appointed Chairman of the Board

Mr Nick Stephens first joined Neuro-Bio in Summer 2019 as a Non Executive Director (NED) to the Board, and therefore is very familiar with all aspects of the company from our scientific approach, through to our individual team members. However, following Dr Edward...

read more
Healthy Ageing Birax UK-Israel Webinar, 14 October 2020

Healthy Ageing Birax UK-Israel Webinar, 14 October 2020

The goal of this Conference is to balance molecular advances with translational and clinical research, incorporating social, economic, environmental, and ethical aspects that are critical for the aged. By integrating the multiple aspects of ageing in a single...

read more
Closure of Latest Funding Round

Closure of Latest Funding Round

We are delighted that, despite the Covid-19 crisis and lab lockdown, we have been able to raise over £1.3m mezzanine B2 funding for the continuation of our pioneering research on Alzheimer’s disease. We are very grateful to our existing investors for their continued...

read more
James Barratt joins Neuro-Bio

James Barratt joins Neuro-Bio

Neuro-Bio welcomes James Barratt as part of the team. James is studying for a BSc in Pharmacology at Nottingham Trent University, and is currently working as an intern for Neuro-Bio. Neuro-Bio’s novel focus to Alzheimer’s is what encouraged him to apply, along with...

read more
Rosie Barnett joins Neuro-Bio

Rosie Barnett joins Neuro-Bio

Neuro-Bio welcomes Rosie Barnett as part of the  team. Rosie is currently in her third year studying pharmacology as part of her BSc sandwich course at Nottingham Trent University. She has joined the company working as an intern, to gain valuable laboratory experience...

read more

NEURO-BIO IS NOW REOPENING!

Following our last post back in April, when we all went into lockdown, the Neuro-Bio team is very excited to be returning to the Culham offices and laboratories. The admin staff have been busy making sure our work areas comply with the covid-19 government guidelines,...

read more

NEURO-BIO GOES VIRTUAL TEMPORARILY

Following the government guidelines in response to covid-19 and for the safety of the team, the Culham office and laboratories are temporarily closed until the current lock-down is lifted. We are however operational from our respective bases at home: should you need...

read more
Neuro-Bio receives public donation

Neuro-Bio receives public donation

Neuro-Bio Ltd would like to extend their heart-felt gratitude to Ms Josie Duffy, who has donated £900.00 of fundraising to Neuro-Bio Ltd. Josie’s mother suffered with Alzheimer’s Disease, and as a result Josie has become a strong advocate of Neuro-Bio, as well as...

read more
New partnership for Neuro-Bio

New partnership for Neuro-Bio

Weronkia Buczek has been awarded a MRC DiMeN Doctoral Training Partnership for her PhD. The title of the project is ‘Molecular characterisation of the in vivo targets and mechanism of action of an acetylcholinesterase-derived peptide upregulated in Alzheimer’s...

read more
Will Ponting joins the Biomarker team

Will Ponting joins the Biomarker team

Neuro-Bio welcomes Will Ponting as part of the Biomarker team. Will has recently graduated from the University of Reading with a BSc degree in Psychology and is joining us to gain valuable experience working in a laboratory setting. He is very interested in...

read more
ArabicChinese (Simplified)EnglishRussian